200 related articles for article (PubMed ID: 18474944)
1. Urothelial carcinogenesis in the urinary bladder of rats treated with naveglitazar, a gamma-dominant PPAR alpha/gamma agonist: lack of evidence for urolithiasis as an inciting event.
Long GG; Reynolds VL; Lopez-Martinez A; Ryan TE; White SL; Eldridge SR
Toxicol Pathol; 2008 Feb; 36(2):218-31. PubMed ID: 18474944
[TBL] [Abstract][Full Text] [Related]
2. Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of action.
Dominick MA; White MR; Sanderson TP; Van Vleet T; Cohen SM; Arnold LE; Cano M; Tannehill-Gregg S; Moehlenkamp JD; Waites CR; Schilling BE
Toxicol Pathol; 2006; 34(7):903-20. PubMed ID: 17178691
[TBL] [Abstract][Full Text] [Related]
3. Neoplastic and non-neoplastic changes in F-344 rats treated with Naveglitazar, a gamma-dominant PPAR alpha/gamma agonist.
Long GG; Reynolds VL; Dochterman LW; Ryan TE
Toxicol Pathol; 2009 Oct; 37(6):741-53. PubMed ID: 19700659
[TBL] [Abstract][Full Text] [Related]
4. Subchronic urinary bladder effects of muraglitazar in male rats.
Van Vleet TR; White MR; Sanderson TP; Cohen SM; Cano M; Arnold LL; Waites CR; Schilling BE; Mitroka J; Dominick MA
Toxicol Sci; 2007 Mar; 96(1):58-71. PubMed ID: 17132713
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers for early effects of carcinogenic dual-acting PPAR agonists in rat urinary bladder urothelium in vivo.
Egerod FL; Nielsen HS; Iversen L; Thorup I; Storgaard T; Oleksiewicz MB
Biomarkers; 2005; 10(4):295-309. PubMed ID: 16240504
[TBL] [Abstract][Full Text] [Related]
6. Histopathology of the urinary bladders of cynomolgus monkeys treated with PPAR agonists.
Hardisty JF; Anderson DC; Brodie S; Cline JM; Hahn FF; Kolenda-Roberts H; Lele SM; Lowenstine LJ
Toxicol Pathol; 2008 Oct; 36(6):769-76. PubMed ID: 18776159
[TBL] [Abstract][Full Text] [Related]
7. Generalized cellular hypertrophy is induced by a dual-acting PPAR agonist in rat urinary bladder urothelium in vivo.
Oleksiewicz MB; Thorup I; Nielsen HS; Andersen HV; Hegelund AC; Iversen L; Guldberg TS; Brinck PR; Sjogren I; Thinggaard UK; Jørgensen L; Jensen MB
Toxicol Pathol; 2005; 33(5):552-60. PubMed ID: 16076770
[TBL] [Abstract][Full Text] [Related]
8. Effects of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on the urine and urothelium of the rat.
Suzuki S; Arnold LL; Pennington KL; Kakiuchi-Kiyota S; Wei M; Wanibuchi H; Cohen SM
Toxicol Sci; 2010 Feb; 113(2):349-57. PubMed ID: 19858066
[TBL] [Abstract][Full Text] [Related]
9. Urine acidification has no effect on peroxisome proliferator-activated receptor (PPAR) signaling or epidermal growth factor (EGF) expression in rat urinary bladder urothelium.
Achanzar WE; Moyer CF; Marthaler LT; Gullo R; Chen SJ; French MH; Watson LM; Rhodes JW; Kozlosky JC; White MR; Foster WR; Burgun JJ; Car BD; Cosma GN; Dominick MA
Toxicol Appl Pharmacol; 2007 Sep; 223(3):246-56. PubMed ID: 17663016
[TBL] [Abstract][Full Text] [Related]
10. Urinary physiologic and chemical metabolic effects on the urothelial cytotoxicity and potential DNA adducts of o-phenylphenol in male rats.
Smith RA; Christenson WR; Bartels MJ; Arnold LL; St John MK; Cano M; Garland EM; Lake SG; Wahle BS; McNett DA; Cohen SM
Toxicol Appl Pharmacol; 1998 Jun; 150(2):402-13. PubMed ID: 9653072
[TBL] [Abstract][Full Text] [Related]
11. Effects of dietary dimethylarsinic acid on the urine and urothelium of rats.
Arnold LL; Cano M; St John M; Eldan M; van Gemert M; Cohen SM
Carcinogenesis; 1999 Nov; 20(11):2171-9. PubMed ID: 10545422
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor agonists and bladder cancer: lessons from animal studies.
Tseng CH; Tseng FH
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2012; 30(4):368-402. PubMed ID: 23167631
[TBL] [Abstract][Full Text] [Related]
13. Urinary crystal formation and urothelial effects of pyroxasulfone administered to male rats.
Kyoya T; Arnold LL; Pennington KL; Kakiuchi-Kiyota S; Terada M; Abe K; Cohen SM
Toxicol Mech Methods; 2020 Nov; 30(9):656-671. PubMed ID: 32746684
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity and regenerative proliferation as the mode of action for diuron-induced urothelial carcinogenesis in the rat.
da Rocha MS; Nascimento MG; Cardoso AP; de Lima PL; Zelandi EA; de Camargo JL; de Oliveira ML
Toxicol Sci; 2010 Jan; 113(1):37-44. PubMed ID: 19812366
[TBL] [Abstract][Full Text] [Related]
15. Rodent carcinogenicity profile of the antidiabetic dual PPAR alpha and gamma agonist muraglitazar.
Tannehill-Gregg SH; Sanderson TP; Minnema D; Voelker R; Ulland B; Cohen SM; Arnold LL; Schilling BE; Waites CR; Dominick MA
Toxicol Sci; 2007 Jul; 98(1):258-70. PubMed ID: 17426106
[TBL] [Abstract][Full Text] [Related]
16. Dimethylarsinic acid: results of chronic toxicity/oncogenicity studies in F344 rats and in B6C3F1 mice.
Arnold LL; Eldan M; Nyska A; van Gemert M; Cohen SM
Toxicology; 2006 Jun; 223(1-2):82-100. PubMed ID: 16677751
[TBL] [Abstract][Full Text] [Related]
17. Cotinine, a major nicotine metabolite, induces cell proliferation on urothelium in vitro and in vivo.
Suzuki S; Cohen SM; Arnold LL; Pennington KL; Kato H; Naiki T; Naiki-Ito A; Yamashita Y; Takahashi S
Toxicology; 2020 Jan; 429():152325. PubMed ID: 31678612
[TBL] [Abstract][Full Text] [Related]
18. Orally administered nicotine effects on rat urinary bladder proliferation and carcinogenesis.
Suzuki S; Cohen SM; Arnold LL; Kato H; Fuji S; Pennington KL; Nagayasu Y; Naiki-Ito A; Yamashita Y; Takahashi S
Toxicology; 2018 Apr; 398-399():31-40. PubMed ID: 29501575
[TBL] [Abstract][Full Text] [Related]
19. Effect of sulfosulfuron on the urine and urothelium of male rats.
Arnold LL; Cano M; St John MK; Healy CE; Cohen SM
Toxicol Pathol; 2001; 29(3):344-52. PubMed ID: 11444256
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
